Related Experiment Video
Updated: Apr 12, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis
Hong-Yuan Chen1, Eric S Clayman2, Wei-Feng Ma3
11 Department of Pathogen Biology and Immunology, School of Basic Courses, Guangdong Pharmaceutical University , Guangzhou, People's Republic of China .
Abstract:
Many malignant tumors express high levels of the chemokine receptor CXCR4, and the interaction between CXCR4 and its ligand, SDF-1, promotes migration, invasion, and metastasis of breast cancer cells. Therefore, blocking the interaction between CXCR4 and SDF-1 could alter the tumor's metastatic phenotype and control the development and progression of cancers. We used a cellular phenotypic knockout strategy and developed a novel recombinant gene, AdSDF-1α/54/KDEL, which contains an adenovirus vector, a mutant form of SDF-1 that lacks a C-terminal α-helix, and a KDEL tetrapeptide sequence that promotes retention at the endoplasmic reticulum (ER). We hypothesized that SDF-1α/54/KDEL could efficiently block metastasis of breast cancer cells with less inflammatory side effects than SDF-1α/KDEL. Using the MCF-7 cell line, which expresses a stable, high level of CXCR4, we found that SDF-1α/54/KDEL efficiently becomes localized at the ER of tumor cells, where it specifically binds to newly synthesized CXCR4 and prevents it from reaching the cell surface. Chemotaxis and invasion assays revealed that the cells treated with SDF-1α/54/KDEL failed to migrate toward SDF-1. We also found that SDF-1α/54/KDEL impaired lung metastasis of metastatic breast cancer by decreasing CXCR4 on the cell surface. The novel recombinant gene, SDF-1α/54/KDEL, played an instrumental role in blocking SDF-1/CXCR4-mediated cell migration, and we found that this gene-based strategy for targeting the SDF-1/CXCR4 axis offers a very effective alternative method for preventing metastasis of breast cancer and other cancers expressing high levels of CXCR4.
Insights
A novel gene therapy targeting the SDF-1/CXCR4 interaction effectively blocks breast cancer metastasis. This approach prevents cancer cell migration by retaining CXCR4 within tumor cells, offering a new strategy against metastatic breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Malignant tumors, including breast cancer, often overexpress the chemokine receptor CXCR4.
- The CXCR4 and its ligand SDF-1 interaction drives cancer cell migration, invasion, and metastasis.
- Targeting the SDF-1/CXCR4 axis is a promising strategy to control cancer progression.
Purpose of the Study:
- To develop and evaluate a novel gene therapy, AdSDF-1α/54/KDEL, for blocking breast cancer metastasis.
- To investigate the efficacy of SDF-1α/54/KDEL in preventing SDF-1/CXCR4-mediated cancer cell migration and invasion.
- To assess the potential of this gene-based strategy as an alternative treatment for CXCR4-expressing cancers.
Main Methods:
- Development of a recombinant adenovirus vector (AdSDF-1α/54/KDEL) encoding a mutant SDF-1.
- Utilizing a cellular phenotypic knockout strategy with the MCF-7 breast cancer cell line.
- Assessing SDF-1α/54/KDEL localization, CXCR4 binding, and effects on cell migration and invasion in vitro and in vivo.
Main Results:
- SDF-1α/54/KDEL successfully localized to the endoplasmic reticulum (ER) of tumor cells.
- The mutant SDF-1 specifically bound to newly synthesized CXCR4, preventing its cell surface expression.
- Cells treated with SDF-1α/54/KDEL exhibited significantly reduced migration and invasion, and impaired lung metastasis.
- The therapy effectively decreased cell surface CXCR4 levels in metastatic breast cancer models.
Conclusions:
- The novel gene SDF-1α/54/KDEL effectively blocks SDF-1/CXCR4-mediated breast cancer cell migration and metastasis.
- This gene-based strategy offers a promising therapeutic approach for preventing metastasis in breast cancer and other CXCR4-expressing malignancies.
- SDF-1α/54/KDEL demonstrates potential for reduced inflammatory side effects compared to other SDF-1 targeting methods.
Related Concept Videos
02:34Inhibition of Cdk Activity
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...